Stay updated on Extension Study of Lirentelimab in Eosinophilic Gastritis Clinical Trial
Sign up to get notified when there's something new on the Extension Study of Lirentelimab in Eosinophilic Gastritis Clinical Trial page.

Latest updates to the Extension Study of Lirentelimab in Eosinophilic Gastritis Clinical Trial page
- Check5 days agoChange DetectedRevision updated to v3.4.3; the previous revision v3.4.2 has been removed.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe page now shows Revision: v3.4.2 and the previous funding-status notice and Revision: v3.4.1 banner were removed.SummaryDifference0.4%

- Check41 days agoChange DetectedThe page displays a government funding status notice and updates the UI version label from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check48 days agoChange DetectedGlossary toggle added to improve term explanations, and the page now includes a QC-related label ('Last Update Submitted that Met QC Criteria'), a capitalization update for 'No FEAR Act Data', and a new revision tag ('Revision: v3.4.0').SummaryDifference0.2%

- Check84 days agoChange DetectedAdded a Locations section listing participating states and sites (Alabama, Arizona, California, Colorado, Florida, Illinois, Louisiana, Massachusetts, Minnesota, Missouri, Nevada, New York, North Carolina, Ohio, Pennsylvania, Tennessee, Texas, Utah, Washington). Updated to Revision: v3.3.3.SummaryDifference2%

- Check106 days agoChange DetectedFooter now shows Revision: v3.3.2 instead of v3.3.1. No study content or navigation changes are visible.SummaryDifference0.0%

Stay in the know with updates to Extension Study of Lirentelimab in Eosinophilic Gastritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Extension Study of Lirentelimab in Eosinophilic Gastritis Clinical Trial page.